During these difficult times, Boston BioProducts will continue to provide our customers and protect our employees during the COVID-19 outbreak. As a critical manufacturer of chemicals, buffers, and reagents, we will take the necessary precautions to support both our OEM partners and research customers in their fight against COVID-19 and continuation of necessary research.
Cycloheximide is an antibiotic produced by Streptomyces griseus. Inhibits eukaryotic cells protein synthesis, leading to cell growth arrest and cell death. Since it inhibits eukaryotic but not prokaryotic protein synthesis, it is active against many yeasts and fungi, but not bacteria.